Stay updated on Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor change to the site’s current version display.
    Difference
    0.0%
    Check dated 2026-04-24T06:15:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:43:27.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:16:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor version update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-11T23:36:10.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Site revision updated to v3.4.2. The previous administrative notes, including the lapse in government funding notice and the v3.4.1 revision, were removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:21:07.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and the NIH Clinical Center's openness was added, and the revision note was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:41:03.000Z thumbnail image

Stay in the know with updates to Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.